REdI 2024 | D2S04-2 - Q&A Discussion Panel
U.S. Food and Drug Administration
0:00 / 0:00
REdI 2024 | D2S04-2 - Q&A Discussion Panel
88 просмотров · 1 год назад
U.S. Food and Drug Administration
200 тыс. подписчиков
88 просмотров · 1 год назад
The last of three Q&A discussion panels for day two of Regulatory Education for Industry (REdI) Annual Conference 2024.
**No Timestamps**
Speakers:
Jessica Bernhardt, MS
ESG Program Manager
Division of Application Services (DAS)
Enterprise Application Branch (EAB)
Office of Digital Transformation (ODT)
Office of Information Management and Technology (OIMT) | FDA
Bin Duan
ESG NextGen Lead Architect CTO
Precise Software Solutions Inc.
Qi Liu, PhD, MStat, FCP
Associate Director for Innovation & Partnership
Office of Clinical Pharmacology (OCP)
Office of Translational Sciences (OTS)
Center for drug Evaluation and Research (CDER) | FDA
Learn more at: https://www.fda.gov/drugs/news-events...
-----------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2024 Playlist - • 2024 CDER Small Business and Industry Assi...
SBIA LinkedIn - / cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter - / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367